Why Canopy Growth (TSX:WEED) Stock Fell 17% in May

Canopy Growth Corp’s (TSX:WEED)(NYSE:CGC) potential multi-billion acquisition of New York-based Acreage Holdings has drawn a lot of criticism.

| More on:

Canopy Growth (TSX:WEED)(NYSE:WEED) lost 17% of its value in May.

There are two reasons investors fled its stock in the past month. One of them is a sector-wide problem and the other is specific to Canopy itself. Neither will likely be permanently scarring, but there could be further declines in June. Here’s why.

The first issue with investors is its announced multi-billion potential deal to buy New York-based Acreage Holdings for US$3.4 billion. Although there is a lot of support for the tie-up of the two companies, the deal will only happen if cannabis is legalized federally in the U.S. Until then, Acreage gets $300 million in a cash downpayment, and the two companies will share intelligence with each other as they continue to press Washington to move faster on legalization.

As I said, not everyone is happy about the deal. Fool contributor David Jagielski recently discussed the possibility that the deal could fall through.

Mercato Capital Management, which owns 2.7% of Acreage’s stock, believes that the company’s value, once cannabis is legalized, would be worth a lot more than the US$3.4 billion Canopy Growth is currently offering. Investors who hold Canopy Growth stock understand that CEO Bruce Linton’s arrangement is a smart way to get a foot in the door of the U.S. market without running afoul of U.S. laws and regulations.

However, if the June 19 vote fails to get enough shareholder support, Canopy Growth will be back at square one with other big players a little wiser to the company’s Trojan Horse solution. That could have consequences on the stock for some time after the vote is held.

The second thing weighing on Canopy Growth’s stock in May is the underwhelming earnings results of some cannabis producers combined with the fact that three of Canada’s largest pot producers — Aurora Cannabis, Tilray, and Cronos Group — all had good quarterly results on the top line.

Investors have no idea what Canopy Growth’s results will look like when it reports earnings June 20. Until then, WEED shares should remain in a downward trend.     

Up almost 49% in 2019, investors still ought to be happy with its year-to-date performance. 

Fool contributor Will Ashworth has no position in any stocks mentioned.  

More on Cannabis Stocks

Yellow caution tape attached to traffic cone
Cannabis Stocks

2 Risky Stocks That Could Send Your $100,000 Investment to $0

Cannabis stocks look risky because price wars, dilution, and regulation can turn one weak quarter into a long drawdown.

Read more »

Pot stocks are a riskier investment
Cannabis Stocks

My Biggest Investing Regret in 2025 Was Buying This Stock

Canopy Growth is a cautionary reminder to buy businesses, not headlines, especially in hype-driven sectors like cannabis.

Read more »

Yellow caution tape attached to traffic cone
Cannabis Stocks

2 Popular Stocks That Could Wipe Out a $100,000 Nest Egg

Aurora Cannabis (TSX:ACB) is one stock that could wipe out your nest egg.

Read more »

Farmer smiles near cannabis crop
Cannabis Stocks

Here’s Why I Wouldn’t Touch Canopy Growth Stock With a 10-Foot Pole

Down almost 99% from all-time highs, Canopy Growth is a beaten-down cannabis stock that remains a high-risk investment in 2026.

Read more »

Cannabis business and marijuana industry concept as the shadow of a dollar sign on a group of leaves
Cannabis Stocks

2 Stocks That Could Turn $100,000 Into $0 Faster Than You Think

Canopy Growth and Plug Power are two unprofitable stocks that remain high-risk investments for shareholders in 2026.

Read more »

Pot stocks are a riskier investment
Cannabis Stocks

Will Canopy Growth Keep the Losing Streak Going in 2026?

Canopy Growth Corp (TSX:WEED) was one of the market's biggest losers in 2025.

Read more »

Farmer smiles near cannabis crop
Cannabis Stocks

TFSA Investors: An Undervalued Cannabis Stock You Can Buy for $500 Right Now

Down almost 70% from all-time highs, Curaleaf is a TSX cannabis stock that trades at an attractive valuation in December…

Read more »

Farmer smiles near cannabis crop
Cannabis Stocks

Can Canopy Growth Stock Finally Recover in 2026, as Donald Trump Might Ease Cannabis Restrictions?

Down over 99% from all-time highs, Canopy Growth stock might recover in 2026 if the Trump administration reclassifies cannabis products.

Read more »